Dr. Mariam Alexander
Claim this profileMedical University of South Carolina
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
17 reported clinical trials
28 drugs studied
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
MET positive
2Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
MET positive
Affiliated Hospitals
Clinical Trials Mariam Alexander is currently running
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Olomorasib
for Non-Small Cell Lung Cancer
The main purpose of this study is to assess if olomorasib in combination with pembrolizumab is more effective than the pembrolizumab and placebo combination in part A in participants with resected KRAS G12C-mutant NSCLC and to assess if olomorasib in combination with durvalumab is more effective than the durvalumab and placebo combination in part B in participants with unresectable KRAS G12C-mutant non-small cell lung cancer. The study may last up to 3 years for each participant.
Recruiting1 award Phase 38 criteria
More about Mariam Alexander
Clinical Trial Related4 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Mariam Alexander has experience with
- Carboplatin
- Pembrolizumab
- Pemetrexed
- Paclitaxel
- Nivolumab
- Cisplatin
Breakdown of trials Mariam Alexander has run
Lung Cancer
Non-Small Cell Lung Cancer
Lung Carcinoma
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mariam Alexander specialize in?
Mariam Alexander focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Mariam Alexander currently recruiting for clinical trials?
Yes, Mariam Alexander is currently recruiting for 8 clinical trials in Charleston South Carolina. If you're interested in participating, you should apply.
Are there any treatments that Mariam Alexander has studied deeply?
Yes, Mariam Alexander has studied treatments such as Carboplatin, Pembrolizumab, Pemetrexed.
What is the best way to schedule an appointment with Mariam Alexander?
Apply for one of the trials that Mariam Alexander is conducting.
What is the office address of Mariam Alexander?
The office of Mariam Alexander is located at: Medical University of South Carolina, Charleston, South Carolina 29425 United States. This is the address for their practice at the Medical University of South Carolina.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.